Findings

What do systematic reviews say?

4,808 questions · 8,953 findings · 827 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1,891 · 21.1%GRADE not reported 380 · 4.2%Very low 2,100 · 23.5%Low 2,449 · 27.4%Moderate 1,684 · 18.8%High 449 · 5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Oestrogen therapy alone vs surgery

Objective improvement or cure of POP symptoms · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs surgery

Generic quality of life measures · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs surgery

Participant adherence to intervention · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs surgery

Minor adverse effects: vaginal events · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs surgery

Major adverse events · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs no treatment or placebo

Objective improvement or cure of POP symptoms · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs no treatment or placebo

Generic quality of life measures · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs no treatment or placebo

Participant adherence to intervention · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs no treatment or placebo

Minor adverse effects: vaginal events · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs no treatment or placebo

Major adverse events · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs pelvic floor muscle training (PFMT)

Subjective improvement or cure of POP symptoms · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oestrogen therapy alone vs pelvic floor muscle training (PFMT)

Improvement or cure of associated sexual symptoms · women with POP

The review found no eligible studies for this question.

1 finding from 1 review

Oestrogen therapy for treating pelvic organ prolapse in postmenopausal women 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prebiotics and anti‐inflammatory therapy vs anti‐inflammatory therapy

Clinical remission · Patients with active mild to moderate ulcerative colitis

The review found no eligible studies for this question.

1 finding from 1 review

Prebiotics for induction and maintenance of remission in ulcerative colitis 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prebiotics and anti‐inflammatory therapy vs anti‐inflammatory therapy

Clinical improvement (Lichtiger index) (4 weeks) · Patients with active mild to moderate ulcerative colitis

1 finding from 1 review

Prebiotics for induction and maintenance of remission in ulcerative colitis 2024 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low

Prebiotics and anti‐inflammatory therapy vs anti‐inflammatory therapy

Quality of life · Patients with active mild to moderate ulcerative colitis

The review found no eligible studies for this question.

1 finding from 1 review

Prebiotics for induction and maintenance of remission in ulcerative colitis 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prebiotics and anti‐inflammatory therapy vs anti‐inflammatory therapy

Total adverse events · Patients with active mild to moderate ulcerative colitis

The review found no eligible studies for this question.

1 finding from 1 review

Prebiotics for induction and maintenance of remission in ulcerative colitis 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prebiotics and anti‐inflammatory therapy vs anti‐inflammatory therapy

Withdrawals due to adverse events · Patients with active mild to moderate ulcerative colitis

The review found no eligible studies for this question.

1 finding from 1 review

Prebiotics for induction and maintenance of remission in ulcerative colitis 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Medium‐dose UVA‐1 phototherapy (50 J/cm²) vs low‐dose UVA‐1 phototherapy (20 J/cm²)

Primary outcome: Global improvement of disease activity or damage assessed by a medical practitioner or by participants · children and adults with active morphea (circumscribed morphea, linear scleroderma (with trunk/limb variant and head variant), generalised…

1 finding from 1 review

Interventions for morphea 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Low

Medium‐dose UVA‐1 phototherapy (50 J/cm²) vs low‐dose UVA‐1 phototherapy (20 J/cm²)

Adverse events associated with treatment · children and adults with active morphea (circumscribed morphea, linear scleroderma (with trunk/limb variant and head variant), generalised…

Medium‐dose UVA‐1 phototherapy (50 J/cm²) showed no clear difference in primary outcome: Adverse effects compared with low‐dose UVA‐1 phototherapy (20 J/cm²) (low certainty).

1 finding from 1 review

Interventions for morphea 2019 · Cochrane Headline outcomes only
RR 1 [0.91, 1.1]
1 study · 44 participants
Low

Medium‐dose UVA‐1 phototherapy (50 J/cm²) vs low‐dose UVA‐1 phototherapy (20 J/cm²)

Secondary outcome: Improvement of disease activity (skin softening) · children and adults with active morphea (circumscribed morphea, linear scleroderma (with trunk/limb variant and head variant), generalised…

1 finding from 1 review

Interventions for morphea 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 36 participants
Low